Absence of MHC-II expression by lymph node stromal cells results in autoimmunity

37Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

How lymph node stromal cells (LNSCs) shape peripheral T-cell responses remains unclear. We have previously demonstrated that murine LNSCs, lymphatic endothelial cells (LECs), blood endothelial cells (BECs), and fibroblastic reticular cells (FRCs) use the IFN-γ–inducible promoter IV (pIV) of the MHC class II (MHCII) transactivator CIITA to express MHCII. Here, we show that aging mice (>1 yr old) in which MHCII is abrogated in LNSCs by the selective deletion of pIV exhibit a significant T-cell dysregulation in LNs, including defective Treg and increased effector CD4+ and CD8+ T-cell frequencies, resulting in enhanced peripheral organ T-cell infiltration and autoantibody production. The proliferation of LN-Tregs interacting with LECs increases following MHCII up-regulation by LECs upon aging or after exposure to IFN-γ, this effect being abolished in mice in which LECs lack MHCII. Overall, our work underpins the importance of LNSCs, particularly LECs, in supporting Tregs and T-cell tolerance.

Cite

CITATION STYLE

APA

Dubrot, J., Duraes, F. V., Harlé, G., Schlaeppi, A., Brighouse, D., Madelon, N., … Hugues, S. (2018). Absence of MHC-II expression by lymph node stromal cells results in autoimmunity. Life Science Alliance, 1(6). https://doi.org/10.26508/lsa.201800164

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free